M06.0A, Rheumatoid arthritis without rheumatoid factor, other specified site

CGS-J15-L39427, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J15

CGS-J18-L39427, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J18

A56795, Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)

J5

WPS-J5-L34594, Nerve Conduction Studies and Electromyography

J5

WPS-J5-L34633, Erythropoiesis Stimulating Agents (ESAs)

J5

WPS-J5-L37205, Chemotherapy Drugs and their Adjuncts

J5

WPS-J5-L39481, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J5

A59536, Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J5

A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

J5

A55639, Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions

J5

A57478, Billing and Coding: Nerve Conduction Studies and Electromyography

J5

A52423, Billing and Coding: Infliximab and biosimilars

J6

NGS-J6-L34380, Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)

J6

A56537, Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)

J6

NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

J6

A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

J6

WPS-J8-L39481, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis

J8

WPS-J8-L34594, Nerve Conduction Studies and Electromyography

J8

WPS-J8-L34633, Erythropoiesis Stimulating Agents (ESAs)

J8

WPS-J8-L37205, Chemotherapy Drugs and their Adjuncts

J8